Remote Patient Monitoring Market Analysis

Indication (Oncology, Diabetes, Hypertension, COPD, Congestive Heart Failure)

The global remote patient monitoring market is segmented and analyzed for demand and supply by indication into oncology, diabetes, hypertension, COPD, and congestive heart failure, out of which, the oncology segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted for the rising cases of cancer globally, increasing awareness regarding healthcare owing to advancements in medical treatment, and increasing access to insurance. For instance, nearly 400 new cases of cancer per 100,000 individuals are diagnosed every year.

Our in-depth analysis of the global market includes the following segments:

By Monitoring Type	Multi-Parameter Blood Glucose Respiratory Cardiac Monitoring Others
By Type	Wireless Wired
By Component	Devices Software
By Indication	Oncology Diabetes Hypertension COPD Congestive Heart Failure
By End-User	Clinics Hospitals Others

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of remote patient monitoring is estimated at USD 9.87 billion.

The remote patient monitoring market size was over USD 8.53 billion in 2024 and is set to cross USD 88.88 billion by the end of 2037, growing at more than 19.5% CAGR during the forecast period i.e., between 2025-2037. Growing cases of cardiovascular diseases and rising prevalence of diabetes across the globe will drive the market growth.

North America industry is predicted to hold largest revenue share by 2037, driven by growing demand for low-cost treatment along with increasing wireless and portable systems adoption in the region.

The major players in the market include F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Abbott Laboratories, Bio Telemetry, Inc., Boston Scientific Corporation, Omron Corporation, Masimo Corporation, Edward Lifesciences Corporation, Nihon Kohden Corporation, Medtronic plc.

Remote Patient Monitoring Market Analysis